Mark Lappe serves as Executive at REPROS THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Mark Lappe has executed 56 insider transactions totaling $21.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 20, 2008 involved selling 34,000 shares valued at $304.0K.
Mark Lappe currently holds 705,548 shares of REPROS THERAPEUTICS INC. (RPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Lappe has been a net buyer of RPRX stock. They have purchased $16.5M and sold $5.2M worth of shares.
Mark Lappe's most recent insider trade was on Mar 20, 2008, when they sold 34,000 shares at $8.94 per share.
Get notified when new Form 4 filings are submitted
| $8.90 |
| Discretionary |
| Mar 17, 2008 | RPRX | $472.7K | Sale | 55,357 | $8.54 | Discretionary |
| Mar 14, 2008 | RPRX | $225.9K | Sale | 26,300 | $8.59 | Discretionary |
| Dec 21, 2007 | RPRX | $375.2K | Purchase | 40,000 | $9.38 | Discretionary |
| Dec 20, 2007 | RPRX | $569.4K | Purchase | 60,000 | $9.49 | Discretionary |